Market Overview:
The global cough suppressant drugs market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of respiratory diseases and growing demand for over-the-counter (OTC) drugs. Based on type, the global cough suppressant drugs market is segmented into dry cough and wet cough. Dry cough is further sub-segmented into viral and bacterial dry coughs. Wet coughing is further sub-segmented into infectious and noninfectious wet coughing. In terms of application, the global market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and other applications such as clinics/physicians’ offices etc.). Geographically, the global market has been segmented into North America, Latin America Europe Asia Pacific & MEA regions respectively).
Product Definition:
Cough suppressant drugs are medications that help to stop or lessen coughing. They work by reducing the amount of mucus in the airways and by blocking the nerve signals that cause coughing. Cough suppressant drugs are important because they can help to improve quality of life for people who have persistent coughs, which can often interfere with sleep, work, and daily activities.
Dry Cough:
Dry cough is a common condition characterized by the lack of production of mucous fluid by the lungs. The most common symptom associated with dry cough is productive expectoration, which may or may not be accompanied by airway obstruction. Coughing can be initiated either from the base of the lungs (mediastinal) or from just above the diaphragm (lateral).
Wet Cough:
Wet cough is a condition in which the mucous membranes of the respiratory tract are filled with fluid. The most common symptom associated with wet cough is Production of excess phlegm (mucus). It usually occurs when we try to suppress or remove an existing cough, by covering the mouth and/or nose, or by holding our breath. This leads to increased production of mucus and makes breathing difficult.
Application Insights:
The others segment held the largest share of the global cough suppressant drugs market in 2017. This segment includes mail order pharmacies, online pharmacies and other retail outlets that offer medicines directly to customers through internet or phone without the help of a medical professional. The demand for these drugs is generally higher in countries where there are fewer hospital pharmacies due to less availability of reliable cold chain infrastructure.
Hospital application is expected to be one of the fastest-growing segments over the forecast period owing to increasing government funding for improving healthcare facilities at primary level hospitals across developing countries such as India, China and Brazil. These factors are likely to increase product demand in this segment over the forecast period.
Cough suppressants sold as oral liquids, tablets or capsules are effective against both dry coughs.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high awareness levels and availability of a wide range of products. Asia Pacific is anticipated to witness lucrative growth over the next eight years owing to rising demand for OTC drugs, increasing disposable income, and presence of untapped opportunities in emerging countries such as China & India. Moreover, growing healthcare infrastructure coupled with increasing investments by multinational companies will boost regional growth further on account of various product launches taking place at a faster pace than other regions. For instance, GlaxoSmithKline launched its new product Benlysta in Japan in February 2018 which is an anti-tussive spray that contains codeine phosphate syrup and dextromethorphan hydrobromide (DXM).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental conditions. This is expected to drive the demand for cough suppressant drugs in the coming years.
- Growing awareness about the benefits of cough suppressants: There is a growing awareness among people about the benefits of using cough suppressants, which is expected to boost demand for these drugs in the coming years.
- Rising number of product launches: The number of product launches in this market is rising as manufacturers are focusing on introducing new products with better efficacy and safety profiles to cater to the needs of consumers. This will help boost growth prospects for this market in the coming years.
- Increasing adoption by pediatric population: Cough suppressant drugs are increasingly being adopted by pediatric population owing to their efficacy and safety profile, which is likely to propel market growth during forecast period 2017-2025 . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Cough Suppressant Drugs Market Research Report
By Type
Dry Cough, Wet Cough
By Application
Hospital, Retail Pharmacy, Online Pharmacy, Others
By Companies
Perrigo Company, Vernalis, Tris Pharma, Pfizer, Acella Pharmaceuticals, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Cough Suppressant Drugs Market Report Segments:
The global Cough Suppressant Drugs market is segmented on the basis of:
Types
Dry Cough, Wet Cough
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Retail Pharmacy, Online Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Perrigo Company
- Vernalis
- Tris Pharma
- Pfizer
- Acella Pharmaceuticals
- GlaxoSmithKline
Highlights of The Cough Suppressant Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry Cough
- Wet Cough
- By Application:
- Hospital
- Retail Pharmacy
- Online Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cough Suppressant Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cough suppressant drugs are medications that help to reduce or stop the cough reflex. They work by blocking the action of certain chemicals in the body that cause coughing.
Some of the major players in the cough suppressant drugs market are Perrigo Company, Vernalis, Tris Pharma, Pfizer, Acella Pharmaceuticals, GlaxoSmithKline.
The cough suppressant drugs market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cough Suppressant Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cough Suppressant Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cough Suppressant Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cough Suppressant Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cough Suppressant Drugs Market Size & Forecast, 2018-2028
4.5.1 Cough Suppressant Drugs Market Size and Y-o-Y Growth
4.5.2 Cough Suppressant Drugs Market Absolute $ Opportunity
Chapter 5 Global Cough Suppressant Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cough Suppressant Drugs Market Size Forecast by Type
5.2.1 Dry Cough
5.2.2 Wet Cough
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cough Suppressant Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cough Suppressant Drugs Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cough Suppressant Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cough Suppressant Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cough Suppressant Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Cough Suppressant Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cough Suppressant Drugs Market Size Forecast by Type
9.6.1 Dry Cough
9.6.2 Wet Cough
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cough Suppressant Drugs Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cough Suppressant Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Cough Suppressant Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cough Suppressant Drugs Market Size Forecast by Type
10.6.1 Dry Cough
10.6.2 Wet Cough
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cough Suppressant Drugs Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cough Suppressant Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cough Suppressant Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cough Suppressant Drugs Market Size Forecast by Type
11.6.1 Dry Cough
11.6.2 Wet Cough
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cough Suppressant Drugs Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cough Suppressant Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Cough Suppressant Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cough Suppressant Drugs Market Size Forecast by Type
12.6.1 Dry Cough
12.6.2 Wet Cough
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cough Suppressant Drugs Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cough Suppressant Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cough Suppressant Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cough Suppressant Drugs Market Size Forecast by Type
13.6.1 Dry Cough
13.6.2 Wet Cough
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cough Suppressant Drugs Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cough Suppressant Drugs Market: Competitive Dashboard
14.2 Global Cough Suppressant Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Perrigo Company
14.3.2 Vernalis
14.3.3 Tris Pharma
14.3.4 Pfizer
14.3.5 Acella Pharmaceuticals
14.3.6 GlaxoSmithKline
